Drug Type Oligonucleotide |
Synonyms- |
Target |
Action blockers |
Mechanism Nav1.7 blockers(Sodium channel protein type IX alpha subunit blockers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Pain | Discovery | United States | 22 Mar 2024 |





